CNBX Pharmaceuticals, Inc. (CNBX)

0.0002 0.00 (0.00%) USD  |  OTCM  |  Jun 08, 16:00
More

CNBX Pharmaceuticals SG&A Expense (Quarterly) : 0.073M for Feb. 28, 2026

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for CNBX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Cocrystal Pharma, Inc. 1.21M
GB Sciences, Inc. --
Arvinas, Inc. 19.10M
Fulcrum Therapeutics, Inc. 8.102M
Definium Therapeutics, Inc. 17.74M